Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal for ImmunoTherapy of Cancer

Topics

Biology

Biochemistry

Chemistry

Medicine

Cancer Oncology

Show all topics

DOI

10.1186/2051-1426-2-3

License

CC-BY-NC-ND

Other Formats

PDF